Picture of IO Biotech logo

IOBTQ IO Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Io Biotech Announces Publication Of Phase 1/2 Melanoma Clinical Trial Results In Nature Medicine

Dec 9 (Reuters) - IO Biotech Inc  IOBT.O :
    * IO BIOTECH ANNOUNCES PUBLICATION OF PHASE 1/2 MELANOMA
CLINICAL
TRIAL RESULTS IN NATURE MEDICINE

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX3GPWhN
Further company coverage:  IOBT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IO Biotech

See all news